Inactive Instrument
NicOx SA Share Price Euronext Paris
Stocks
NCOX
FR0000074130
Pharmaceuticals
OTC Markets Traded| Market Cap | 3.37Cr 3.93Cr 3.15Cr 2.88Cr 5.44Cr 376.64Cr 5.5Cr 37Cr 15Cr 189.13Cr 15Cr 14Cr 625.75Cr | P/E 2026 * |
-5.46x | P/E 2027 * | 38.3x |
|---|---|---|---|---|---|
| Enterprise Value | 3.37Cr 3.93Cr 3.15Cr 2.88Cr 5.44Cr 376.64Cr 5.5Cr 37Cr 15Cr 189.13Cr 15Cr 14Cr 625.75Cr | EV / Sales 2026 * |
11.2x | EV / Sales 2027 * | 3.37x |
| Free-Float |
99.65% | Yield 2026 * |
-
| Yield 2027 * | - |
| 1 day | -7.95% |
| Manager | Title | Age | Since |
|---|---|---|---|
Gavin Spencer
CEO | Chief Executive Officer | 55 | 28/02/2024 |
Sandrine Gestin
DFI | Director of Finance/CFO | 58 | 01/01/2015 |
Doug Hubatsch
CTO | Chief Tech/Sci/R&D Officer | - | 13/12/2021 |
| Director | Title | Age | Since |
|---|---|---|---|
Gavin Spencer
BRD | Director/Board Member | 55 | 08/04/2024 |
Damian Marron
CHM | Chairman | 64 | 16/07/2024 |
Marc Bozec
BRD | Director/Board Member | - | 16/07/2024 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -7.95% | -9.39% | - | - | 3.93Cr | |
| +2.06% | +13.55% | +79.92% | +39.27% | 37TCr | |
| +0.78% | +1.54% | +26.23% | -13.38% | 7.02TCr | |
| +0.39% | +3.60% | +50.49% | +154.56% | 1.23TCr | |
| -0.50% | +0.08% | -1.72% | -1.04% | 848.82Cr | |
| +3.23% | -1.03% | -12.64% | +1.29% | 489.03Cr | |
| +2.43% | +0.72% | -26.70% | +17.08% | 454.36Cr | |
| -5.18% | -30.32% | -25.38% | +5.50% | 303.71Cr | |
| +0.58% | -8.30% | +1.19% | +43.23% | 262.21Cr | |
| -3.09% | -6.39% | -16.61% | -9.00% | 204.73Cr | |
| Average | -0.72% | +0.05% | +8.31% | +26.39% | 5.33TCr | |
| Weighted average by Cap. | +1.70% | +8.67% | +66.40% | +32.82% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 30L 35.01L 28.07L 25.66L 48.42L 34Cr 48.93L 3.32Cr 1.29Cr 17Cr 1.31Cr 1.29Cr 56Cr | 1Cr 1.17Cr 93.55L 85.53L 1.61Cr 111.73Cr 1.63Cr 11Cr 4.3Cr 56Cr 4.38Cr 4.29Cr 185.63Cr |
| Net income | -60L -70.01L -56.13L -51.32L -96.84L -67Cr -97.87L -6.64Cr -2.58Cr -34Cr -2.63Cr -2.57Cr -111.38Cr | 10L 11.67L 9L 9L 16.14L 11Cr 16.31L 1.11Cr 43.04L 5.61Cr 43.81L 42.86L 19Cr |
| Net Debt | - | - |
Employees
-
Sector
Pharmaceuticals
